Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB)

CUSIP: 45782T105

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
27,969,231
Total 13F shares
5,623,690
Share change
-539,613
Total reported value
$12,725,267
Put/Call ratio
211%
Price per share
$2.31
Number of holders
78
Value change
-$10,010,248
Number of buys
47
Number of sells
37

Security key

45782T105

Report period

Q2 2025

Institutions

78

Top holders

10

Top shareholders of INMB - Inmune Bio, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
HIGHBRIDGE CAPITAL MANAGEMENT LLC
13D/G
5.2%
1,454,400
$3,359,664 $0 30 Jun 2025
CVI Investments, Inc.
13D/G
4.9%
1,396,279
$3,225,404 -$239,596 30 Jun 2025
Praetorian PR LLC
13F 13D/G
Company · Kupperman Harris
3.4%
from 13D/G
865,000
$6,755,650 31 Mar 2025
BlackRock, Inc.
13F
Company
3.4%
948,362
$7,406,707 31 Mar 2025
13F
VANGUARD GROUP INC
13F
Company
3%
826,613
$6,455,848 31 Mar 2025
13F
RAYMOND JAMES FINANCIAL INC
13F
Company
1.4%
382,041
$2,983,740 31 Mar 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.3%
364,862
$2,849,867 31 Mar 2025
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.86%
241,248
$1,884,147 31 Mar 2025
13F
STATE STREET CORP
13F
Company
0.84%
236,128
$1,844,160 31 Mar 2025
13F
GatePass Capital, LLC
13F
Company
0.84%
235,000
$1,835,350 31 Mar 2025
13F
Rhenman & Partners Asset Management AB
13F
Company
0.64%
178,284
$1,392,398 31 Mar 2025
13F
NORTHERN TRUST CORP
13F
Company
0.55%
152,445
$1,190,595 31 Mar 2025
13F
UBS Group AG
13F
Company
0.49%
137,315
$1,072,430 31 Mar 2025
13F
Dauntless Investment Group, LLC
13F
Company
0.47%
130,680
$1,020,611 31 Mar 2025
13F
MAI Capital Management
13F
Company
0.38%
106,797
$834,085 31 Mar 2025
13F
CITADEL ADVISORS LLC
13F
Company
0.36%
101,511
$792,801 31 Mar 2025
13F
Pekin Hardy Strauss, Inc.
13F
Company
0.34%
94,300
$736,483 31 Mar 2025
13F
Westside Investment Management, Inc.
13F
Company
0.32%
89,200
$696,660 31 Mar 2025
13F
MORGAN STANLEY
13F
Company
0.3%
84,464
$659,663 31 Mar 2025
13F
MARSHALL WACE, LLP
13F
Company
0.21%
58,087
$453,661 31 Mar 2025
13F
Bank of New York Mellon Corp
13F
Company
0.2%
54,923
$428,948 31 Mar 2025
13F
Waratah Capital Advisors Ltd.
13F
Company
0.19%
53,774
$419,975 31 Mar 2025
13F
Fermata Advisors, LLC
13F
Company
0.18%
49,997
$390,477 31 Mar 2025
13F
SIMPLEX TRADING, LLC
13F
Company
0.15%
42,809
$334,000 31 Mar 2025
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.15%
41,320
$322,709 31 Mar 2025
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.15%
40,716
$317,992 31 Mar 2025
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.14%
40,295
$314,704 31 Mar 2025
13F
NATIONAL BANK OF CANADA /FI/
13F
Company
0.14%
39,500
$308,489 31 Mar 2025
13F
DEUTSCHE BANK AG\
13F
Company
0.14%
38,011
$296,866 31 Mar 2025
13F
XTX Topco Ltd
13F
Company
0.13%
36,919
$288,337 31 Mar 2025
13F
Laird Norton Wetherby Trust Company, LLC
13F
Company
0.13%
36,600
$285,846 31 Mar 2025
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.11%
30,563
$238,697 31 Mar 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.11%
30,393
$237,369 31 Mar 2025
13F
ROYAL BANK OF CANADA
13F
Company
0.11%
29,786
$233,000 31 Mar 2025
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.09%
25,139
$196,336 31 Mar 2025
13F
Cambridge Investment Research Advisors, Inc.
13F
Company
0.08%
23,075
$180,000 31 Mar 2025
13F
COMMONWEALTH EQUITY SERVICES, LLC
13F
Company
0.07%
19,888
$155,000 31 Mar 2025
13F
BARCLAYS PLC
13F
Company
0.07%
19,842
$154,967 31 Mar 2025
13F
WOLVERINE TRADING, LLC
13F
Company
0.07%
19,392
$145,828 31 Mar 2025
13F
HSBC HOLDINGS PLC
13F
Company
0.07%
19,385
$144,806 31 Mar 2025
13F
RHUMBLINE ADVISERS
13F
Company
0.07%
19,153
$149,575 31 Mar 2025
13F
JANE STREET GROUP, LLC
13F
Company
0.06%
18,159
$141,822 31 Mar 2025
13F
PharVision Advisers, LLC
13F
Company
0.06%
17,241
$134,652 31 Mar 2025
13F
Diametric Capital, LP
13F
Company
0.06%
16,535
$129,138 31 Mar 2025
13F
Nuveen, LLC
13F
Company
0.06%
16,518
$129,006 31 Mar 2025
13F
GROUP ONE TRADING LLC
13F
Company
0.06%
15,526
$121,258 31 Mar 2025
13F
Financial Advocates Investment Management
13F
Company
0.06%
15,500
$121,055 31 Mar 2025
13F
OSAIC HOLDINGS, INC.
13F
Company
0.05%
13,925
$108,753 31 Mar 2025
13F
Quadrature Capital Ltd
13F
Company
0.04%
12,301
$95,825 31 Mar 2025
13F
Focus Partners Advisor Solutions, LLC
13F
Company
0.04%
11,589
$90,510 31 Mar 2025
13F

Institutional Holders of Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB) as of Q2 2025

As of 30 Jun 2025, Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB) was held by 78 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,623,690 shares. The largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, UBS Group AG, GEODE CAPITAL MANAGEMENT, LLC, RAYMOND JAMES FINANCIAL INC, STATE STREET CORP, Dauntless Investment Group, LLC, Rhenman & Partners Asset Management AB, NORTHERN TRUST CORP, and XTX Topco Ltd. This page lists 79 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
81
Q2 2025 holders
78
Holder diff
-3
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 Value $ Q2 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .